Standard BioTools Inc.
LAB
$0.68
$0.034.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.76M | 127.07M | 19.28M | -34.69M | -33.46M |
| Total Depreciation and Amortization | 1.27M | 1.41M | 5.29M | 1.60M | 2.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.21M | -158.49M | 5.17M | 10.42M | 9.71M |
| Change in Net Operating Assets | 7.96M | -16.59M | -30.93M | 471.00K | 1.08M |
| Cash from Operations | -10.31M | -46.60M | -1.19M | -22.20M | -20.67M |
| Capital Expenditure | -344.00K | -570.00K | -476.00K | -886.00K | -1.89M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 24.99M | 363.22M | -- | -- | -- |
| Other Investing Activities | -10.24M | -171.56M | -7.56M | -5.80M | 29.39M |
| Cash from Investing | 14.41M | 191.09M | -8.04M | -6.68M | 27.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 120.00K | 78.00K | 746.00K | 0.00 | 308.00K |
| Repurchase of Common Stock | -258.00K | -118.00K | -126.00K | -112.00K | -200.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -138.00K | -40.00K | 620.00K | -112.00K | 108.00K |
| Foreign Exchange rate Adjustments | 294.00K | 115.00K | -100.00K | -203.00K | 788.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.25M | 144.57M | -8.71M | -29.20M | 7.73M |